Kyle Piskel - 15 Nov 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Principal Accounting Officer
Signature
/s/ Kyle Piskel by Eric Billings, attorney-in-fact
Issuer symbol
ADPT
Transactions as of
15 Nov 2021
Transactions value $
$0
Form type
4
Filing time
17 Nov 2021, 19:00:33
Previous filing
03 Nov 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +3.84K +134.07% $0.00 6.7K 15 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Award $0 +9.59K $0.00 9.59K 15 Nov 2021 Common Stock 9.59K $32.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest with respect to 1/4 of such shares on November 15, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.